341 related articles for article (PubMed ID: 33777292)
1. Diagnosis of latent tuberculosis among HIV infected patients in Ilorin, Nigeria using tuberculin skin test and interferon gamma release assay.
Aladesanmi AO; Ojuawo OB; Aladesanmi OO; Fawibe AE; Desalu OO; Ojuawo AB; Opeyemi CM; Adio MO; Oluwaloniola V; Salami AK
Pan Afr Med J; 2021; 38():24. PubMed ID: 33777292
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
4. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
5. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
Chkhartishvili N; Kempker RR; Dvali N; Abashidze L; Sharavdze L; Gabunia P; Blumberg HM; Del Rio C; Tsertsvadze T
BMC Infect Dis; 2013 Nov; 13():513. PubMed ID: 24176032
[TBL] [Abstract][Full Text] [Related]
6. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
Gran G; Aßmus J; Dyrhol-Riise AM
BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Tuberculin Skin Test (TST) and T-SPOT.TB Tests for Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV-infected Patients].
Binay UD; Fincancı M; Fersan E; Karakeçili F
Mikrobiyol Bul; 2019 Oct; 53(4):388-400. PubMed ID: 31709936
[TBL] [Abstract][Full Text] [Related]
8. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
[TBL] [Abstract][Full Text] [Related]
10. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
LaCourse SM; Cranmer LM; Matemo D; Kinuthia J; Richardson BA; Horne DJ; John-Stewart G
J Acquir Immune Defic Syndr; 2017 May; 75(1):128-136. PubMed ID: 28141782
[TBL] [Abstract][Full Text] [Related]
11. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
12. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays.
Talati NJ; Gonzalez-Diaz E; Mutemba C; Wendt J; Kilembe W; Mwananyanda L; Chomba E; Allen S; del Rio C; Blumberg HM
BMC Infect Dis; 2011 Sep; 11():264. PubMed ID: 21962029
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
[TBL] [Abstract][Full Text] [Related]
15. Concordance between the tuberculin skin test and interferon gamma release assay (IGRA) for diagnosing latent tuberculosis infection in patients with systemic lupus erythematosus and patient characteristics associated with an indeterminate IGRA.
Cho H; Kim YW; Suh CH; Jung JY; Um YJ; Jung JH; Kim HA
Lupus; 2016 Oct; 25(12):1341-8. PubMed ID: 26985011
[TBL] [Abstract][Full Text] [Related]
16. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
[TBL] [Abstract][Full Text] [Related]
17. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
